The effect of ultrasonic nebulized salbutamol in the first attacked wheezy infants. |
Soo Young Kweon, Young Mi Hong, Gyung Hee Kim, Seung Joo Lee, Keun Lee |
Department of Pediatrics, College of Medicine, Ewha Womans University, Seoul, Korea |
첫 발병한 천명성 기관지염 영아에서 Salbutamol
분무제의 치료효과 |
권수영, 홍영미, 김경희, 이승주, 이근 |
이화여자대학교 의과대학 소아과학교실 |
Received: 9 May 1991 • Accepted: 6 August 1991 |
|
Abstract |
Wheezing is one of the most common symptom in the first 2 year of life.
Although the effect of bronchodilator in wheezy infants was still debating, various form of
bronchodilator has been tried untill now.
This study was done to estimate the value of ultrasonic nebulized salbutamol as a bronchodilator
test and maintenance therapy compared to epinephrine and aminophylline in 44 wheezy infants below
24 months of age who were first admitted to EWUH, Department of Pediatrics, from November 1989
to August 1990.
The subjects were randomly divided into ultrasonic nebulized salbutamol and subcutaneous epine-
phrine group for a bronchodilator test, and divided again into ultrasonic nebulized salbutamol and IV
aminophylline group as a maintenance therapy.
The results were as follows:
1) The response rates of bronchodilator in salbutamol group, was 25% which is not significantly
different to 16.7% in epinephrine group.
2) The response rates according to age were not different, 22.2% in infants below 6 months, 15.0%
in 6〜 12 months, 30.0% in 12〜 18 months and 20% in 18~24 months.
3) In young infants with the first wheezing, the maintenance therapeutic effect of ultrasonic
nebulized salbutamol was similar to aminophylline in changes of respiratory distress scores and the
durations of wheezing.
The side effects of ultrasonic nebulized salbutamol were significantly lower than IV aminophylline
(p<0.01).
This study demonstrate the effectiveness and safety of ultrasonic nebulized salbutamol in the
treatment of the infants below 24 monsths of age with first wheezing. |
Key Words:
Wheezy infant, Nebulized salbutamol |
|